TD Cowen Issues Pessimistic Forecast for Atlassian (NASDAQ:TEAM) Stock Price

Atlassian (NASDAQ:TEAMGet Free Report) had its price objective dropped by investment analysts at TD Cowen from $205.00 to $175.00 in a report released on Tuesday,Benzinga reports. The brokerage currently has a “hold” rating on the technology company’s stock. TD Cowen’s target price would indicate a potential upside of 42.96% from the company’s current price.

Other analysts have also issued reports about the stock. The Goldman Sachs Group restated a “buy” rating and issued a $260.00 price objective on shares of Atlassian in a report on Friday, October 31st. Macquarie lowered their target price on Atlassian from $250.00 to $240.00 and set an “outperform” rating for the company in a research note on Monday, November 3rd. Truist Financial set a $210.00 price target on Atlassian in a research report on Friday, October 31st. UBS Group decreased their price objective on Atlassian from $215.00 to $185.00 and set a “neutral” rating for the company in a report on Friday, October 24th. Finally, Canaccord Genuity Group reissued a “buy” rating and set a $230.00 price objective on shares of Atlassian in a research report on Wednesday, October 22nd. Twenty-one research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $235.38.

Check Out Our Latest Analysis on TEAM

Atlassian Price Performance

Shares of TEAM stock opened at $122.41 on Tuesday. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.26 and a current ratio of 1.26. Atlassian has a fifty-two week low of $115.53 and a fifty-two week high of $326.00. The firm has a market cap of $32.21 billion, a P/E ratio of -172.41, a P/E/G ratio of 18.28 and a beta of 0.88. The business’s 50 day moving average price is $151.58 and its 200-day moving average price is $164.95.

Atlassian (NASDAQ:TEAMGet Free Report) last released its quarterly earnings results on Thursday, October 30th. The technology company reported $1.04 earnings per share for the quarter, beating the consensus estimate of $0.83 by $0.21. The business had revenue of $1.43 billion for the quarter, compared to analysts’ expectations of $1.40 billion. Atlassian had a negative net margin of 3.38% and a negative return on equity of 7.11%. The firm’s revenue for the quarter was up 20.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.77 earnings per share. On average, equities research analysts anticipate that Atlassian will post -0.34 earnings per share for the current year.

Insider Activity

In other news, Director Scott Farquhar sold 7,665 shares of the company’s stock in a transaction that occurred on Tuesday, January 20th. The shares were sold at an average price of $118.19, for a total value of $905,926.35. Following the transaction, the director owned 375,585 shares in the company, valued at approximately $44,390,391.15. This represents a 2.00% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Michael Cannon-Brookes sold 7,665 shares of the firm’s stock in a transaction that occurred on Tuesday, January 20th. The shares were sold at an average price of $118.19, for a total transaction of $905,926.35. Following the sale, the chief executive officer directly owned 375,585 shares of the company’s stock, valued at $44,390,391.15. This trade represents a 2.00% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 566,379 shares of company stock worth $87,553,359 over the last three months. 36.66% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Atlassian

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Capco Asset Management LLC bought a new stake in shares of Atlassian in the 2nd quarter worth $25,000. Physician Wealth Advisors Inc. boosted its position in shares of Atlassian by 60.4% during the third quarter. Physician Wealth Advisors Inc. now owns 162 shares of the technology company’s stock valued at $26,000 after buying an additional 61 shares during the last quarter. Geneos Wealth Management Inc. increased its holdings in Atlassian by 447.2% in the 1st quarter. Geneos Wealth Management Inc. now owns 197 shares of the technology company’s stock worth $42,000 after buying an additional 161 shares in the last quarter. Atlantic Union Bankshares Corp raised its position in Atlassian by 19,900.0% in the 3rd quarter. Atlantic Union Bankshares Corp now owns 200 shares of the technology company’s stock worth $32,000 after buying an additional 199 shares during the last quarter. Finally, Board of the Pension Protection Fund bought a new position in Atlassian during the 4th quarter valued at about $32,000. 94.45% of the stock is owned by institutional investors.

Key Atlassian News

Here are the key news stories impacting Atlassian this week:

  • Positive Sentiment: BTIG remains bullish after Atlassian’s Data Center pricing update, signaling continued confidence in revenue/corporate demand dynamics. BTIG Stays Bullish on Atlassian (TEAM) After Data Center Pricing Update
  • Positive Sentiment: A recent analysis argues AI-driven disruption fears are overblown, stressing Atlassian’s strong switching costs, data ownership, and complex workflows that protect revenue and margins — a bullish read for long-term holders. Atlassian: AI Fears Are Overblown
  • Neutral Sentiment: Mizuho lowered its price target from $245 to $225 but maintained an Outperform rating — a downward revision to upside expectations but still a positive stance relative to the market. Mizuho lowers price target to $225 (Outperform)
  • Negative Sentiment: TD Cowen trimmed its target to $175 and moved to a Hold rating, reducing analyst conviction and lowering implied upside — a headwind for momentum. TD Cowen lowers price target to $175 (Hold)
  • Negative Sentiment: Insider sales: CEO Michael Cannon-Brookes and co-founder/director Scott Farquhar each sold 7,665 shares (same trade), trimming their holdings by ~2% at ~$118.19 per share — a signal some investors read as negative even though remaining ownership remains sizable. SEC filings here and here. Farquhar SEC Filing Cannon-Brookes SEC Filing

About Atlassian

(Get Free Report)

Atlassian Corporation Plc is a software company headquartered in Sydney, Australia, best known for developing collaboration, project management and software development tools. Founded in 2002 by Mike Cannon-Brookes and Scott Farquhar, Atlassian grew from a small engineering-focused team into a publicly traded company after its initial public offering in 2015. The company serves a global customer base that spans small teams to large enterprises across technology, financial services, government and other sectors.

Atlassian’s product portfolio centers on tools designed to help teams plan, build and support software and business processes.

See Also

Analyst Recommendations for Atlassian (NASDAQ:TEAM)

Receive News & Ratings for Atlassian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atlassian and related companies with MarketBeat.com's FREE daily email newsletter.